4-(3,4,5-trimethoxyphenylamino)quinoline-7-carbonitrile

ID: ALA4575895

PubChem CID: 155563824

Max Phase: Preclinical

Molecular Formula: C19H17N3O3

Molecular Weight: 335.36

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(Nc2ccnc3cc(C#N)ccc23)cc(OC)c1OC

Standard InChI:  InChI=1S/C19H17N3O3/c1-23-17-9-13(10-18(24-2)19(17)25-3)22-15-6-7-21-16-8-12(11-20)4-5-14(15)16/h4-10H,1-3H3,(H,21,22)

Standard InChI Key:  BLWQIEISIMYCHD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    5.4142  -18.8491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4131  -18.0267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7050  -17.6202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9934  -18.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9985  -18.8565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7112  -19.2634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7031  -16.7989    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2799  -17.6254    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2893  -19.2738    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5748  -18.8656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2764  -16.8041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4098  -16.3845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1272  -19.2598    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1296  -20.0811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4181  -20.4883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4202  -21.3088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1338  -21.7203    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8412  -20.4819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8445  -21.2988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5531  -21.7047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2588  -21.2907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2516  -20.4706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5424  -20.0726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9735  -21.6964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6882  -22.1000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  3  7  1  0
  4  8  1  0
  5  9  1  0
  9 10  1  0
  8 11  1  0
  7 12  1  0
  1 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 19  1  0
 18 14  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 18  2  0
 24 25  3  0
 21 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4575895

    ---

Associated Targets(Human)

GAK Tchem Serine/threonine-protein kinase GAK (1150 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NLK Tchem Serine/threonine protein kinase NLK (977 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
COQ8A Tbio Chaperone activity of bc1 complex-like, mitochondrial (552 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RIPK2 Tchem Serine/threonine-protein kinase RIPK2 (1546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACVR1 Tchem Activin receptor type-1 (1516 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BMPR1B Tchem Bone morphogenetic protein receptor type-1B (563 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAF1 Tclin Serine/threonine-protein kinase RAF (4169 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EPHA1 Tchem Ephrin type-A receptor 1 (1040 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EPHA8 Tchem Ephrin type-A receptor 8 (790 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FYN Tclin Tyrosine-protein kinase FYN (5308 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Huh-7 (12904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

dengue virus type 2 (2400 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 335.36Molecular Weight (Monoisotopic): 335.1270AlogP: 3.88#Rotatable Bonds: 5
Polar Surface Area: 76.40Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.01CX LogP: 2.95CX LogD: 2.95
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.76Np Likeness Score: -0.94

References

1. Asquith CRM, Berger BT, Wan J, Bennett JM, Capuzzi SJ, Crona DJ, Drewry DH, East MP, Elkins JM, Fedorov O, Godoi PH, Hunter DM, Knapp S, Müller S, Torrice CD, Wells CI, Earp HS, Willson TM, Zuercher WJ..  (2019)  SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK).,  62  (5): [PMID:30768268] [10.1021/acs.jmedchem.8b01213]
2. Asquith CRM,Treiber DK,Zuercher WJ.  (2019)  Utilizing comprehensive and mini-kinome panels to optimize the selectivity of quinoline inhibitors for cyclin G associated kinase (GAK).,  29  (14.0): [PMID:31129055] [10.1016/j.bmcl.2019.05.025]
3. Saul S,Pu SY,Zuercher WJ,Einav S,Asquith CRM.  (2020)  Potent antiviral activity of novel multi-substituted 4-anilinoquin(az)olines.,  30  (16): [PMID:32631507] [10.1016/j.bmcl.2020.127284]

Source